Multiple Myeloma: The second issue of Emerging Cancer Therapeutics focuses on multiple
myelomas also known as plasma cell myeloma, KahlerÌs Disease and myelomatosis. It is
estimated that over 20,000 new cases are diagnosed each year with over 10,000 people
dying from these malignancies. Multiple myelomas are highly treatable but rarely curable.
Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their
management. Management options and outcomes for individuals with multiple myelomas …

Multiple myelomas are a less frequent cancer site among both sexes. On a worldwide scale,
it is estimated that about 86 000 incident cases occur annually, accounting for about 0.8% of
all new cancer cases. About 63 000 subjects are reported to die from the disease each year,
accounting for 0.9% of all cancer deaths. Geographically, the frequency is very unevenly
distributed in the world with the highest incidence in the industrialised regions of
Australia/New Zealand, Europe and North America. Incidence and mortality seem to be …